Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE DEBT - Marpai Health Convertible Notes - 2019 Convertible Notes (Details)

v3.21.2
CONVERTIBLE DEBT - Marpai Health Convertible Notes - 2019 Convertible Notes (Details)
12 Months Ended
Jul. 29, 2021
Oct. 24, 2019
USD ($)
Dec. 31, 2019
USD ($)
item
Debt Instrument [Line Items]      
Term of debt 6 months    
2019 Convertible Notes      
Debt Instrument [Line Items]      
Aggregate principal amount     $ 1,500,000
Term of debt     2 years
Minimum gross proceeds of equity financing required for automatic conversion of notes     $ 2,000,000
Price per share determined based on maximum pre-money valuation on a fully diluted basis     $ 8,000,000
Price per share determined based on discount on lowest price per share paid by the investors in financing round     20.00%
Number of times the note amount, plus any accrued and unpaid interest payable upon change in control | item     1.5
Interest rate     8.00%
Purchase Note      
Debt Instrument [Line Items]      
Aggregate principal amount   $ 2,930,000  
Term of debt   5 years  
Minimum gross proceeds of equity financing required for automatic conversion of notes   $ 10,000,000  
Value by which cash price paid per share for equity securities by the investors in Qualified Financing multiplied to determine conversion price   0.80  
Interest rate   6.00%